<DOC>
	<DOCNO>NCT00035087</DOCNO>
	<brief_summary>This study examine whether new investigational drug EPO906 , give intravenous infusion ( IV directly vein ) , effective shrinking tumor prevent growth cell cause colorectal cancer .</brief_summary>
	<brief_title>EPO906 Therapy Patients With Advanced Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<mesh_term>Epothilone B</mesh_term>
	<criteria>Inclusion Criteria Patients must meet follow criterion eligible study : Histologically cytologically document evidence colorectal cancer least one measurable lesion ( previous radiation treatment , target lesion must demonstrate progression since radiation ) The patient fail progressed two prior chemotherapy metastatic disease ( prior chemotherapy must include fluoropyrimidine either Irinotecan oxaliplatin , combination agent , last chemotherapy contain Irinotecan oxaliplatin ) Patients receive adjuvant therapy disease eligible , long relapse within six month complete therapy therapy contain 5FU Irinotecan oxaliplatin administer combination part investigational protocol Must life expectancy great three ( 3 ) month . Exclusion Criteria The following patient eligible study : Patients symptomatic CNS metastasis leptomeningeal involvement Patients unresolved bowel obstruction Patients peripheral neuropathy unresolved diarrhea great Grade 1 Patients severe cardiac insufficiency Patients undergone major surgery cause le 4 week prior study entry Patients radiation therapy chemotherapy within last four week Patients take Coumadin warfarincontaining agent exception low dose Coumadin ( 1 mg less ) maintenance indwell line port History another malignancy within 5 year prior study entry except curatively treat nonmelanoma skin cancer cervical cancer situ Patients active suspect acute chronic uncontrolled infection include abcesses fistulae HIV+ patient Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>colon</keyword>
	<keyword>rectum</keyword>
	<keyword>colorectal</keyword>
	<keyword>rectal</keyword>
	<keyword>cancer</keyword>
	<keyword>tumor</keyword>
	<keyword>tumour</keyword>
	<keyword>neoplasm</keyword>
	<keyword>carcinoma</keyword>
	<keyword>intravenous</keyword>
	<keyword>epothilone</keyword>
</DOC>